Cardiac Rhythm Management Devices Market To Reach $36.19 Billion By 2033

Cardiac Rhythm Management Devices Market Growth & Trends

The global cardiac rhythm management devices market size is expected to reach USD 36.19 billion by 2033, registering a CAGR of 6.35% from 2025 to 2033, according to a new report by Grand View Research, Inc. The key factors driving the market include growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders. According to the Centers for Disease Control and Prevention (CDC), as of September 2021, approximately 659,000 Americans die suffering from heart disease every year. The market was negatively impacted during the COVID-19 pandemic, as elective procedures, including the non-essential cardiovascular procedures, were postponed or canceled during the pandemic.

Major players in the market such as Medtronic; Abbott; and Boston Scientific Corporation, incurred huge losses in their cardiac rhythm management business segments globally. This resulted in negative growth of the market in 2020. The rising demand for handling sudden cardiac arrests is leading to innovation in all types of cardiac rhythm management devices. Innovation with regards to implantable devices includes products, such as subcutaneous and transvenous devices, that aim to increase the comfort level of patients. Swedish Transport Agency ran a program under the test phase, which aimed to deliver AEDs using a drone. This may reduce the delivery time of an AED, increasing the chances of survival with faster treatment.

Therefore, the market is anticipated to grow because of technological advancements and product innovations. Revolutionary technological signs of progress are rapidly transforming the market. These expansions are producing lucrative potentials. An increase in R&D expenditure and new product launches by leading firms further fueled the growth. For instance, in October 2020, Abbott launched its new ICD and CRT-D in India, hence expanding its product portfolio in the country. The company had also received CE Mark approval for its Gallant ICD and CRT-D devices in February 2020. Such factors boost market growth. Key market players account for a significant share of the market owing to their extensive product offerings.

 Request a free sample copy or view report summary: Cardiac Rhythm Management Devices Market Report

Cardiac Rhythm Management Devices Market Report Highlights 

• By product, the pulse generators segment accounted for the largest revenue share of 79.46% in 2024. The leads segment is expected to grow at significant CAGR over the forecast period.

• By end use, the hospitals segment accounted for the largest revenue share of 53.49% in 2024. The ambulatory surgery centers segment is expected to grow at fastest CAGR over the forecast period.

• North America cardiac rhythm management devices market dominated the global market with a share of 45.34% in 2024. The U.S. cardiac rhythm management devices market accounted for the largest market share in North America in 2024.

• North America Cardiac Rhythm Management Devices market dominated the global industry with the largest revenue share of 36.83% in 2024.

• The Asia Pacific cardiac rhythm management devices market is expected to grow fastest during the forecast period. China cardiac rhythm management devices market accounted for the largest market share in the Asia Pacific region in 2024.

Cardiac Rhythm Management Devices Market Segmentation

Grand View Research has segmented global cardiac rhythm management devices market report based on product, end-use and region:

Cardiac Rhythm Management Devices Product Outlook (Unit Volume in ‘000 Units; Average Selling Price [USD per Unit]; Revenue in USD Million, 2021 - 2033)

• Pulse Generators

  • Cardiac Resynchronization Therapy (CRT)

    • CRT-Defibrillator

    • CRT-Pacemakers

  • Defibrillators

    • Implantable Cardioverter Defibrillators (ICD)

    • Transvenous Implantable Cardioverter Defibrillators (TIICDs)

      • Single Chamber

      • Dual Chamber

    • Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)

    • External Defibrillator.

  • Pacemakers

    • Conventional Pacemakers

    • Leadless Pacemakers

• Leads

  • Pacing Leads

    • Standard RV/LV Leads

    • Conduction System Pacing (CSP) / LBBAP Leads

  • Defibrillator Leads

    • Traditional Leads

    • LV Leads

Cardiac Rhythm Management Devices End-use Outlook (Unit Volume in ‘000 Units; Average Selling Price [USD per Unit]; Revenue in USD Million, 2021 - 2033)

• Hospitals

• Ambulatory Surgery Centers

• Others

Cardiac Rhythm Management Devices Regional Outlook (Unit Volume in ‘000 Units; Average Selling Price [USD per Unit]; Revenue in USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Cardiac Rhythm Management Devices Market

• Abbott

• Medtronic

• Boston Scientific Corporation

• Biotronik

• Schiller

• Koninklijke Philips N.V.

• MicroPort Scientific Corporation

• Lepu Medical Technology (Beijing) Co., Ltd.

• Stryker